EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A renal cyst-clear cell renal cell carcinoma comorbidity analysis identifies a FOXM1-positive epithelial COL6A1-CD44 axis that remodels fibroblasts

Hao Lv, Chenyi Ge, Yuming Jin, Yu Fang, Wenqiang Liu, Yan Zhang, Hanzhong Zhang, Chencan Fang, Le Qu, Xin Lu, Wentao Zhang, Nan Zhang und 3 weitere

Translational Oncology · 2026-12 · 74 · 103064

DOI: 10.1016/j.tranon.2026.103064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2026-12. Verfasst von Hao Lv und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, Ch…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Renal cystic conditions are heterogeneous. We used a broad renal cyst-associated disease-gene framework to identify molecular programs shared with clear cell renal cell carcinoma (ccRCC), without modeling a specific cystic disorder or direct cyst-to-cancer progression. METHODS: We identified 237 shared genes between renal cyst disease and ccRCC (TCGA-KIRC), performed functional enrichment, Mendelian randomization, and built a random survival forest (RSF) risk score benchmarked against published signatures and immunotherapy cohorts. Single-cell (Scissor, SCENIC, scTenifoldKnk virtual FOXM1 knockout) and spatial transcriptomics (RCTD, CellChat) were integrated with fibroblast subclustering and oncoPredict drug screening. Candidate FOXM1 inhibitors were prioritized by docking and 100-ns molecular dynamics, with isovitexin validated functionally. RESULTS: The shared program was enriched for epithelial development and ECM remodeling. Two direction-specific Mendelian randomization analyses supported associations between genetic liability to kidney cancer and related renal cystic phenotypes. The RSF score showed robust prognostic discrimination across cohorts and separated immunotherapy outcomes. High-risk tumors were enriched for Tregs, B cells, and fibroblasts. FOXM1+ malignant epithelium represented the high-risk state, with elevated CNV burden and regulon activity; virtual FOXM1 knockout identified COL6A1 and CD44 among 129 significant non-target perturbation hits. Convergent single-cell and spatial analyses nominated a COL6A1-CD44 communication axis associated with fibroblast remodeling, with F5_SFRP2+ fibroblasts as the most plausible receiving state. These fibroblasts showed ECM-remodeling, adverse prognosis, and pathway activation. Isovitexin emerged as a lead FOXM1-targeting compound, significantly suppressing ccRCC proliferation, migration, and invasion. CONCLUSIONS: These findings support a testable communication model involving FOXM1+ epithelium, COL6A1-CD44 and F5_SFRP2+ fibroblasts. The in vitro results also support further evaluation of isovitexin in ccRCC.

Schlagwörter

Stichwörter der Autor:innen

COL6A1Clear cell renal cell carcinomaFOXM1FibroblastRenal cyst

Autor:innen und Institutionen

  • Department of Urology, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China.
  • Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Department of Urology, The First Naval Hospital of Southern Theater Command, Zhanjiang, China.
  • Department of Urology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Department of Urology, Henan Corps Hospital of Chinese People's Armed Police Force, Zhengzhou, Henan, China. Electronic address: zhangwt2059@126.com.
  • Department of Urology, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China. Electronic address: ZhgNAN@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lv, H., Ge, C., Jin, Y., Fang, Y., Liu, W., Zhang, Y., Zhang, H., Fang, C., Qu, L., Lu, X., Zhang, W., Zhang, N., Jiang, A., Wu, L., & Wang, L. (2026). A renal cyst-clear cell renal cell carcinoma comorbidity analysis identifies a FOXM1-positive epithelial COL6A1-CD44 axis that remodels fibroblasts. Translational Oncology, 74, 103064. https://doi.org/10.1016/j.tranon.2026.103064

Vancouver

Lv H, Ge C, Jin Y, Fang Y, Liu W, Zhang Y, et al. A renal cyst-clear cell renal cell carcinoma comorbidity analysis identifies a FOXM1-positive epithelial COL6A1-CD44 axis that remodels fibroblasts. Translational Oncology. 2026;74:103064. doi:10.1016/j.tranon.2026.103064

BibTeX
@article{Lv2026,
  author = {Lv, Hao and Ge, Chenyi and Jin, Yuming and Fang, Yu and Liu, Wenqiang and Zhang, Yan and Zhang, Hanzhong and Fang, Chencan and Qu, Le and Lu, Xin and Zhang, Wentao and Zhang, Nan and Jiang, Aimin and Wu, Lingfeng and Wang, Linhui},
  title = {A renal cyst-clear cell renal cell carcinoma comorbidity analysis identifies a FOXM1-positive epithelial COL6A1-CD44 axis that remodels fibroblasts},
  journal = {Translational Oncology},
  year = {2026},
  volume = {74},
  pages = {103064},
  doi = {10.1016/j.tranon.2026.103064}
}
Kostenlos starten →